Tormod Kyrre Guren

7PUBLICATIONS
69CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.

Petros Grivas, Elena Garralda, Funda Meric-Bernstam

|Dec 05, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.

Jayesh Desai, Guzman Alonso, Se Hyun Kim

|Apr 20, 2022
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.

Louise B Callesen, Julian Hamfjord, Anders K Boysen

|Dec 14, 2021
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours.

Debbie Robbrecht, Christiane Jungels, Morten Mau Sorensen

|Dec 02, 2021
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study.

Julian Hamfjord, Tor Åge Myklebust, Inger Kristin Larsen

|Apr 18, 2020
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.

Jarle Bruun, Kushtrim Kryeziu, Peter W Eide

Pageof 2

Frequent Collaborators

2 joint publications

Marianne G Guren

2 joint publications

Andres Cervantes

1 joint publications

Teijo Pellinen

1 joint publications

Jani Saarela